Home » India Limits Clinical Investigators to Three Trials Simultaneously
India Limits Clinical Investigators to Three Trials Simultaneously
August 26, 2014
Clinical trial investigators in India must limit their work to no more than three trials at any given time, according to one of the mandates in 14 finalized regulations issued by the Central Drugs Standard Control Organization.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor